4.7 Article

A deep learning risk prediction model for overall survival in patients with gastric cancer: A multicenter study

期刊

RADIOTHERAPY AND ONCOLOGY
卷 150, 期 -, 页码 73-80

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2020.06.010

关键词

Gastric cancer; Deep learning; Overall survival; Individualized treatment; Computed tomography

资金

  1. National Key R&D Program of China [2017YFC1308700, 2017YFA0205200, 2017YFC1309100, 2017YFA0700401]
  2. National Natural Science Foundation of China [81971776, 91959130, 81771924, 81227901, 81772006, 81771912, 81930053, 81960314]
  3. National Science Fund for Distinguished Young Scholars [81925023]
  4. Beijing Natural Science Foundation [L182061]
  5. Bureau of International Cooperation of Chinese Academy of Sciences [173211KYSB20160053]
  6. Instrument Developing Project of the Chinese Academy of Sciences [YZ201502]
  7. Youth Innovation Promotion Association CAS [2017175]
  8. Technology Foundation of Guizhou Province [QKHJC [2016]1096]

向作者/读者索取更多资源

Background and purpose: Risk prediction of overall survival (OS) is crucial for gastric cancer (GC) patients to assess the treatment programs and may guide personalized medicine. A novel deep learning (DL) model was proposed to predict the risk for OS based on computed tomography (CT) images. Materials and methods: We retrospectively collected 640 patients from three independent centers, which were divided into a training cohort (center 1 and center 2, n = 518) and an external validation cohort (center 3, n = 122). We developed a DL model based on the architecture of residual convolutional neural network. We augmented the size of training dataset by image transformations to avoid overfitting. We also developed radiomics and clinical models for comparison. The performance of the three models were comprehensively assessed. Results: Totally 518 patients were prepared by data augmentation and fed into DL model. The trained DL model significantly classified patients into high-risk and low-risk groups in training cohort (P-value <0.001, concordance index (C-index): 0.82, hazard ratio (HR): 9.79) and external validation cohort (Pvalue <0.001, C-index: 0.78, HR: 11.76). Radiomics model was developed with selected 24 features and clinical model was developed with three significant clinical variables (P-value <0.05). The comparison illustrated DL model had the best performance for risk prediction of OS according to the C-index (training: DL vs Clinical vs Radiomics = 0.82 vs 0.73 vs 0.66; external validation: 0.78 vs 0.71 vs 0.72). Conclusion: The DL model is a powerful model for risk assessment, and potentially serves as an individualized recommender for decision-making in GC patients. (c) 2020 Elsevier B.V. All rights reserved. Radiotherapy and Oncology 150 (2020) 73-80

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据